Statin Toxic Side Effects: Evidence from 500 Scientific Papers
Grosvenor House Publishing, Ltd
David Evans has already given us two great compendiums: Low Cholesterol Leads to an Early Death: Evidence from 101 Scientific Papers, and Cholesterol and Saturated Fat Prevent Heart Disease: Evidence from 101 Scientific Papers. His latest contribution, Statin Toxic Side Effects is a tour de force, a collection of five hundred studies showing that statin use is associated with greater risk of diabetes, cancer, muscle damage, hypothyroidism, organ failure, liver problems, pancreatitis, peripheral neuropathy, lupus, skin abnormalities, asthma, reduced lung function, reduced cognition, neurodegenerative diseases, depression, suicide, damaged eyes, impotence and birth defects.
And if you think this is a good tradeoff for protection against heart disease, think again. Evans cites thirty-two studies showing that statins won’t help with that either; they are associated with increased risk of serious adverse cardiovascular events, higher cardiac death rates, increased adverse events and death in those undergoing coronary artery bypass surgery, increased risk of death in angioplasty patients, increased risk of heart failure, and double the risk of death in patients with coronary artery disease.
And just for good measure, case reports show that statins increase the risk of osteoarthritis and joint pain, cause both constipation and diarrhea, are associated with colitis, bone loss, tendon rupture, urinary track infectons and general infections including MRSA. The list of adverse conditions associated with low cholesterol is a long one, covering several pages.
If you have a loved one in the clutches of a statin-pushing cardiologist, this would be a good book to give—to both your loved one and the cardiologist. Maybe, just maybe, it will empower your friend or relative to stop taking these terrible drugs; and maybe, just maybe, it will give the cardiologist a twinge of conscience.
What about all those studies showing that statins save lives? Evans sums them up neatly with a chart showing virtual identical numbers of people alive in the treatment and control groups in the thirty-three major studies used to tout statins.
This article appeared in Wise Traditions in Food, Farming and the Healing Arts, the quarterly journal of the Weston A. Price Foundation, Fall 2015